Table 7.
Changes in metabolites explaining variance in vascular function
Class | β | Standard Error | P Value | |
---|---|---|---|---|
Flow-mediated dilation | ||||
Nitrite 80 mg/day | ||||
DG (28:2) | Glycerolipids | −0.646 | 0.045 | 0.044 |
N,N-dimethyl-l-valine | Amino acids | −0.744 | 0.103 | 0.014 |
LysoPE [18:3(9Z,12Z,15Z)/0:0] | Glycerophospholipids | 0.649 | 0.050 | 0.042 |
C19 H50 N11 O13 P S | unknown | −0.810 | 0.238 | 0.005 |
5-Aminoimidazole-4-carboxamide-1-βd-ribofuranosyl 5′-monophosphate | Imidazole ribonucleosides and ribonucleotides | −0.734 | 0.361 | 0.016 |
C35 H62 N O15 P | Unknown | −0.866 | 0.297 | 0.001 |
Nitrite 160 mg/day | ||||
l-glutamine | Carboxylic acid and derivatives | −0.771 | 0.071 | 0.009 |
LysoPC (20:5) | Glycerophospholipids | −0.672 | 0.084 | 0.033 |
PC (18:1/18:1) | Glycerophospholipids | −0.680 | 0.398 | 0.031 |
β-Stiffness index | ||||
Nitrite 160 mg/day | ||||
C34 H53 N6 O2 P | Unknown | 0.785 | 0.167 | 0.007 |
PE (30:0) | Glycerophospholipids | 0.634 | 0.592 | 0.049 |
Cross-sectional compliance | ||||
Nitrite 160 mg/day | ||||
C34 H53 N6 O2 P | Unknown | −0.721 | 0.001 | 0.019 |